Sera Prognostics, on their said earnings call, revealed their earnings report, where CEO Zhenya Lindgardt gave investors a forecast: "We believe 2024 will be an exciting year for Sera with a number of expected catalysts and developments to support commercial expansion and shareholder value." This highlights the company's strategy as they progress in the exploration of the prenatal diagnostics landscape.